SEC Form 4 · accession 0001214659-16-009647
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Colin Hislop
Officer — Chief Medical Officer
Period of report
Feb 12, 2016
Accepted (ET)
Feb 16, 2016 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.86 | Feb 12, 2016 | A | 10,848 | A | — | Feb 12, 2016 | Common Stock | 10,848 | 10,848 | D |
Explanation of responses
- F1This Stock Option vests immediately on February 12, 2016